Adagene Inc. (ADAG)

Adagene Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Adagene Inc. (ADAG) is a Biotechnology company based in CN with a market capitalization of $120.5M. Revenue grew 7332.8% year-over-year and free cash flow was negative at -$15.7M. This page tracks ADAG's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

CN · 138 employees · IPO Feb 9, 2021

Valuation

Valuation & price

$3.67as of May 26, 2026· -23.2% vs 52w high

P/E ratio

Latest-FY diluted EPS

3.41

P/B ratio

Market cap ÷ book equity

Dividend yield

Price — last 12 months

$4.61$3.10$1.58Jul 25Jan 26Jul 26
$1.4152-week range$4.78
Loading valuation history…

Fundamentals

Key fundamentals

$120.5M

Market cap

7332.8%

Revenue growth (YoY)

100.0%

Gross margin

-$15.7M

Free cash flow (USD)

-$68.3M

Net debt

Net cash position

4.8%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

20182025

$1.5M$7.7M

Free cash flow by year

20182025

-$14.8M-$15.7M

Gross margin by year

20212025

100.0%100.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Jul 6, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • Quarterly reportJul 6, 2026Filing

    Interim Results (6-K)

  • 6-K filingApr 17, 2026Filing

    Data Presentation at AACR

  • Annual reportApr 2, 2026Filing

    Annual Report Filed

  • 6-K filingApr 2, 2026Filing

    Underwriting Agreement

  • Annual reportApr 1, 2026Filing

    Annual Report Filed

  • Annual reportApr 1, 2026Filing

    20-F Filed

Questions

Frequently asked questions

What is Adagene Inc.'s market cap?

Adagene Inc. (ADAG) has a market capitalization of $120.5M.

What is ADAG's P/E ratio?

A meaningful P/E ratio is not available for ADAG — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is ADAG's price-to-book (P/B) ratio?

ADAG trades at 3.41 times book value per share.

Are insiders buying ADAG stock?

SEC Form 4 filings show no open-market insider buys at Adagene Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.